Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Tenax Therapeutics
TENX
$68.5M
| $491K | ﹤0.01% |
256
+31
| +14% | +$64.4K |
|
|
ENG
2877
DELISTED
ENGlobal Corp
ENG
| $491K | ﹤0.01% |
61,429
+4,084
| +7% | +$34.2K |
|
2878
Brinker International
EAT
$10.2B
| $486K | ﹤0.01% |
11,400
-92,000
| -89% | -$3.69M |
|
2879
Inuvo
INUV
$14.2M
| $484K | ﹤0.01% |
179,198
-9,321
| -5% | -$26K |
|
2880
Vanguard S&P 500 Value ETF
VOOV
$6.8B
| $483K | ﹤0.01% |
+4,200
| New | +$475K |
|
|
RELV
2881
DELISTED
Reliv International Inc
RELV
| $479K | ﹤0.01% |
107,280
+1,600
| +2% | +$6.89K |
|
|
RTC
2882
DELISTED
Baijiayun Group
RTC
| $478K | ﹤0.01% |
35,942
-1,205
| -3% | -$15.5K |
|
2883
AllianceBernstein
AB
$3.4B
| $477K | ﹤0.01% |
16,264
-85,736
| -84% | -$2.49M |
|
|
SDPI
2884
DELISTED
Superior Drilling Products Inc.
SDPI
| $477K | ﹤0.01% |
488,046
-16,400
| -3% | -$14.7K |
|
|
GRCE
2885
Grace Therapeutics
GRCE
$44.2M
| $475K | ﹤0.01% |
+5,231
| New | +$484K |
|
2886
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.03B
| $474K | ﹤0.01% |
15,592
-21,908
| -58% | -$665K |
|
|
OIG
2887
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $474K | ﹤0.01% |
14,024
+1,688
| +14% | +$51.7K |
|
2888
Forestar Group
FOR
$1.49B
| $473K | ﹤0.01% |
25,880
-19,220
| -43% | -$377K |
|
2889
Aaon
AAON
$7.23B
| $471K | ﹤0.01% |
+15,386
| New | +$497K |
|
2890
ClearOne Inc
CLRO
$15.2M
| $468K | ﹤0.01% |
17,218
+393
| +2% | +$12.8K |
|
2891
Cardiff Oncology
CRDF
$77.1M
| $468K | ﹤0.01% |
309,603
+60,482
| +24% | +$118K |
|
2892
First Internet Bancorp
INBK
$256M
| $465K | ﹤0.01% |
+21,700
| New | +$446K |
|
|
BGMS
2893
Bio Green Med Solution Inc
BGMS
$5.1M
| $464K | ﹤0.01% |
16
+1
| +7% | +$35.3K |
|
|
OPI
2894
DELISTED
Office Properties Income Trust
OPI
| $464K | ﹤0.01% |
+15,155
| New | +$423K |
|
|
SEMG
2895
DELISTED
SEMGROUP CORPORATION
SEMG
| $458K | ﹤0.01% |
28,057
-707,600
| -96% | -$8.26M |
|
2896
Lifecore Biomedical
LFCR
$181M
| $456K | ﹤0.01% |
41,937
-64,800
| -61% | -$705K |
|
2897
Optical Cable Corp
OCC
$149M
| $455K | ﹤0.01% |
128,203
-12,000
| -9% | -$44.2K |
|
|
IIN
2898
DELISTED
IntriCon Corporation
IIN
| $455K | ﹤0.01% |
+23,400
| New | +$452K |
|
2899
Schwab US Mid-Cap ETF
SCHM
$15.3B
| $452K | ﹤0.01% |
24,000
+10,500
| +78% | +$198K |
|
2900
Brookfield
BN
$111B
| $450K | ﹤0.01% |
23,753
-2,197,062
| -99% | -$39.8M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.